Zobrazeno 1 - 10
of 134
pro vyhledávání: '"S Nishtala"'
Autor:
Angel Shabu, Prasad S. Nishtala
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 801-812 (2023)
Objective This study aims to characterize the adverse events (AEs) following the administration of the mRNA-1273 COVID-19 vaccine from the Vaccine Adverse Event Reporting System (VAERS) data. Methods In this case/non-case analysis, reports between 1
Externí odkaz:
https://doaj.org/article/f7517499e3ae41b8b3872ec663390f51
Autor:
Angel Shabu, Prasad S. Nishtala
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 393-409 (2023)
Introduction Current safety data from Phase 3 clinical trials have concluded that apart from transient local and systemic reactions, no safety concerns were identified for the Moderna COVID-19 vaccine (mRNA-1273). However, Phase 3 studies are insuffi
Externí odkaz:
https://doaj.org/article/0c57395c26654f52b45e3db3bc730c5b
Publikováno v:
BMC Geriatrics, Vol 23, Iss 1, Pp 1-17 (2023)
Abstract Background Machine learning-based prediction models have the potential to have a considerable positive impact on geriatric care. Design Systematic review and meta-analyses. Participants Older adults (≥ 65 years) in any setting. Interventio
Externí odkaz:
https://doaj.org/article/64a8322d070e465382a841cf6b0d9744
Publikováno v:
BMC Geriatrics, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background As people age, they accumulate several health conditions, requiring the use of multiple medications (polypharmacy) to treat them. One of the challenges with polypharmacy is the associated increase in anticholinergic exposure to ol
Externí odkaz:
https://doaj.org/article/d01f6514f10643d9ba0728cb521a1e39
Publikováno v:
BMC Geriatrics, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Older adults (aged 65 years and above) constitute the fastest growing population cohort in the western world. There is increasing evidence that the burden of infections disproportionately affects older adults, and hence this vulne
Externí odkaz:
https://doaj.org/article/d00e1f6dc7b4409a88f90a7f1f37ea98
Autor:
Ulrich Bergler, Nagham J. Ailabouni, John W. Pickering, Sarah N. Hilmer, Dee Mangin, Prasad S. Nishtala, Hamish Jamieson, Sponsor-investigator
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background Targeted deprescribing of anticholinergic and sedative medications in older people may improve their health outcomes. This trial will determine if pharmacist-led reviews lead to general practitioners deprescribing anticholinergic
Externí odkaz:
https://doaj.org/article/71fc7b0c3b4f475abce3526a7e771268
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/81c20c57966e4255b66e1b4231caf0e0
Publikováno v:
International Journal of Risk & Safety in Medicine. 34:87-99
BACKGROUND: Recently, antivirals, including remdesivir, have been repurposed to treat COVID-19 infections. Initial concerns have been raised about the adverse renal and cardiac events associated with remdesivir. OBJECTIVE: This study aimed to analyse
Publikováno v:
Nicholls, C, Chyou, T-Y & Nishtala, P S 2023, ' Analysis of the nervous system and gastrointestinal adverse events associated with solifenacin in older adults using the US FDA adverse event reporting system ', International Journal of Risk & Safety in Medicine, vol. 34, no. 1, pp. 63-73 . https://doi.org/10.3233/JRS-210054
BACKGROUND: Antimuscarinics are the backbone of the pharmacological management of overactive bladder. Still, concerns have been raised over the nervous system (NS) adverse drug events (AEs) due to their dissimilarities to muscarinic receptor-subtype
Publikováno v:
Saudi Pharmaceutical Journal, Vol 25, Iss 2, Pp 165-175 (2017)
The study of the magnitude and variation of drug response is defined as pharmacodynamics (PDs). PD models examine plasma concentration and effect relationship. It can predict the archetypal effect (E) of a drug as a function of the drug concentration
Externí odkaz:
https://doaj.org/article/d9dae2ae222d4a32b04e8ca812b69f5c